Search by Drug Name or NDC
NDC 55150-0473-01 Piperacillin and Tazobactam 36; 4.5 g/250mL; g/250mL Details
Piperacillin and Tazobactam 36; 4.5 g/250mL; g/250mL
Piperacillin and Tazobactam is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Eugia US LLC. The primary component is PIPERACILLIN SODIUM; TAZOBACTAM SODIUM.
MedlinePlus Drug Summary
Piperacillin and tazobactam injection is used to treat pneumonia and skin, gynecological, and abdominal (stomach area) infections caused by bacteria. Piperacillin is in a class of medications called penicillin antibiotics. It works by killing bacteria that cause infection. Tazobactam is in a class called beta-lactamase inhibitor. It works by preventing bacteria from destroying piperacillin. Antibiotics such as piperacillin and tazobactam injection will not work for colds, flu, or other viral infections. Taking or using antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.
Related Packages: 55150-0473-01Last Updated: 04/21/2024
MedLinePlus Full Drug Details: Piperacillin and Tazobactam Injection
Product Information
| NDC | 55150-0473 |
|---|---|
| Product ID | 55150-473_80f4bdb8-131e-4485-b7a2-accd596d4cde |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Piperacillin and Tazobactam |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Piperacillin Sodium and Tazobactam Sodium |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 36; 4.5 |
| Active Ingredient Units | g/250mL; g/250mL |
| Substance Name | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM |
| Labeler Name | Eugia US LLC |
| Pharmaceutical Class | Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA217409 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 55150-0473-01 (55150047301)
| NDC Package Code | 55150-473-01 |
|---|---|
| Billing NDC | 55150047301 |
| Package | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (55150-473-01) / 152 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Marketing Start Date | 2023-10-12 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |